13:39 EST Ionis Pharmaceuticals files automatic common stock offering
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IONS:
- Ionis Pharmaceuticals management to meet with Needham
- Ionis shares clinical update from ongoing trial of ION582 for Angelman syndrome
- Ionis reports ‘positive’ two-year results from Phase 2 OLE study of donidalorsen
- Ionis Pharmaceuticals price target raised to $45 from $37 at Barclays
- Ionis Pharmaceuticals reports Q3 EPS ($1.03), consensus ($1.07)